RxDoctor Payments Data

Hayward Edmunds, MD

Anatomic Pathology & Clinical Pathology · Birmingham, ALNPI 1043315922

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $173, 7.2 times the $24 reported in 2022.

$331in general payments, 2019–2025

Across 17 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$66
  • Johnson & Johnson$40
  • Genentech USA, Inc.$32
  • Incyte Corporation$25
  • Sumitomo Pharma America, Inc.$25
  • Lilly USA, LLC$22
  • plus $121 from 7 others

What the payments were for

  • Food & beverage$331100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$331 in reported general payments places this provider in the 85th percentile of 115 anatomic pathology & clinical pathology providers in Alabama.

See all anatomic pathology & clinical pathology providers in Alabama

Medicare billing

Part B allowed, 2024
$109,459
Medicare patients
459
Services billed
2,081

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Birmingham

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →